Annals of Family Medicine

NOVEMBER 20, 2024

Objective: Our study investigates ID prevalence in Alberta from 2010 to 2022 and its association with patient and provider characteristics. We hypothesize that the prevalence of ID in Alberta has been increasing over the past decade based on clinical observations and anecdotes. serum ferritin below 15 μg/mL).

Clinic 130

Clinic Primary Care Electronics Individual 130

Annals of Family Medicine

NOVEMBER 20, 2024

The most recent international guidelines for the management of acute uncomplicated pyelonephritis in adults (2010) recommend treatment to be initiated with a single dose of intravenous (IV) ceftriaxone or an aminoglycoside when the prevalence of fluoroquinolone resistance is unknown or exceeds 10%. Intervention N/A.

Primary Care 130

Primary Care Complication Diagnosis Electronics 130

Annals of Family Medicine

NOVEMBER 20, 2024

Methods Data were from the QUALITY cohort, an ongoing investigation of the natural history of obesity in 630 Quebec families. A prospective analysis was undertaken using data collected in 2008-2010. PA was measured using accelerometers.

Physicals 130

Physicals Education Clinic Families 130

Annals of Family Medicine

JANUARY 27, 2025

METHODS We analyzed national weekly diagnosis data for acute respiratory infections (ICD-10 codes J00-J22) in Poland from 2010 to 2019, covering all 380 county-equivalent administrative regions and encompassing 292 million consultations. Data were aggregated into age brackets.

Diagnosis 130

Diagnosis Diagnose Consulting Government 130

Annals of Family Medicine

NOVEMBER 20, 2024

Using linked administrative databases, we identified all instances of PIP-AP according to the STOPP-START criteria, which have previously been shown to predict adverse clinical events such as ED visits and hospitalizations. Residents were followed for 1 year or to date of death, whichever occurred first.

Patients 130

Patients Provider Individual Hospital 130

Physician's Weekly

JULY 10, 2025

Since 2013 he’s flown to the East Coast scores of times to participate in five clinical trials at the cancer wing of NIH’s Clinical Center. It would force NCI to suspend all new grants or cut existing grants so severely that the gaps will close many labs, said Varmus, who ran NCI from 2010 to 2015.

Government 52

Government Patient-Centered Diagnose IT 52